Kronox Lab Sciences Limited
NSE: KRONOX · Specialty Chemicals
Snapshot
Unlock Kronox Lab Sciences Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Kronox Lab Sciences Limited is a manufacturer of high-purity specialty fine chemicals, including inorganic chemicals, phosphates, and metallic chemicals. The company serves diverse industries such as pharmaceuticals, nutraceuticals, personal care, and animal health through its extensive portfolio of reagents and custom-specification chemicals.
Business Model
The company generates revenue by manufacturing and supplying bulk reagents and specialty chemicals to both domestic and international markets. Its business model focuses on providing high-purity, custom-specification products that cater to stringent quality requirements across various industrial applications.
Growth Outlook
Growth is driven by the increasing demand for high-purity chemicals in the pharmaceutical and nutraceutical sectors. The company continues to expand its product range to include specialized anhydrous and ultra-high purity chemicals to meet evolving industrial standards.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent environmental and safety regulations governing the chemical manufacturing sector.
- Raw Material Price Volatility. Fluctuations in the cost of raw materials and chemical precursors can significantly impact profit margins.
- Export Market Dependency. Exposure to international markets introduces risks associated with geopolitical instability, currency fluctuations, and varying trade policies.
- Competitive Intensity. The specialty chemicals industry is highly fragmented, leading to intense price competition from both domestic and global manufacturers.
Start your research today
Unlock AI insights, financials, peers and live data on Kronox Lab Sciences Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹105 Cr
TTM · standalone
NET PROFIT
₹29 Cr
TTM · standalone
EPS
₹7.79
TTM · standalone
RETURN ON EQUITY
27.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
35.9%
TTM · standalone
P/E
23.7x
Q1 FY27 · standalone
EV/EBITDA
16.8x
Q1 FY27 · standalone
EBITDA MARGIN
38.7%
TTM · standalone
NET PROFIT MARGIN
25.7%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Kronox Lab Sciences LimitedKRONOX | ₹685 Cr | 23.71 | 16.76 | 6.1% | 38.7% | 27.7% | 35.9% | +11.4% |
DMCC Speciality Chemicals Ltd.DMCC | ₹732 Cr | 18.30 | 10.01 | 49.6% | 11.5% | 16.8% | 23.7% | -5.5% |
Chemcon Speciality Chemicals LimitedCHEMCON | ₹727 Cr | 25.80 | 14.44 | 17.4% | 21.1% | 5.7% | 8.2% | -5.8% |
Jayant Agro Organics LimitedJAYAGROGN | ₹692 Cr | 12.73 | 6.95 | 1.9% | 4.6% | 9.2% | 14.0% | -5.0% |
Chembond Chemicals LimitedCHEMBONDCH | ₹684 Cr | 17.97 | 12.38 | — | 15.6% | 18.4% | 23.2% | +32.4% |
Black Rose IndusBLACKROSE | ₹576 Cr | 25.69 | 16.19 | — | 11.0% | 13.9% | 18.9% | +14.7% |
As of Q1 FY27
Financials
Kronox Lab Sciences Limited
NSE: KRONOX · Specialty Chemicals
Snapshot
Unlock Kronox Lab Sciences Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Kronox Lab Sciences Limited is a manufacturer of high-purity specialty fine chemicals, including inorganic chemicals, phosphates, and metallic chemicals. The company serves diverse industries such as pharmaceuticals, nutraceuticals, personal care, and animal health through its extensive portfolio of reagents and custom-specification chemicals.
Business Model
The company generates revenue by manufacturing and supplying bulk reagents and specialty chemicals to both domestic and international markets. Its business model focuses on providing high-purity, custom-specification products that cater to stringent quality requirements across various industrial applications.
Growth Outlook
Growth is driven by the increasing demand for high-purity chemicals in the pharmaceutical and nutraceutical sectors. The company continues to expand its product range to include specialized anhydrous and ultra-high purity chemicals to meet evolving industrial standards.
Key Risks
- Regulatory Compliance. The company faces risks related to stringent environmental and safety regulations governing the chemical manufacturing sector.
- Raw Material Price Volatility. Fluctuations in the cost of raw materials and chemical precursors can significantly impact profit margins.
- Export Market Dependency. Exposure to international markets introduces risks associated with geopolitical instability, currency fluctuations, and varying trade policies.
- Competitive Intensity. The specialty chemicals industry is highly fragmented, leading to intense price competition from both domestic and global manufacturers.
Start your research today
Unlock AI insights, financials, peers and live data on Kronox Lab Sciences Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹105 Cr
TTM · standalone
NET PROFIT
₹29 Cr
TTM · standalone
EPS
₹7.79
TTM · standalone
RETURN ON EQUITY
27.7%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
35.9%
TTM · standalone
P/E
23.7x
Q1 FY27 · standalone
EV/EBITDA
16.8x
Q1 FY27 · standalone
EBITDA MARGIN
38.7%
TTM · standalone
NET PROFIT MARGIN
25.7%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Specialty Chemicals
As of Q1 FY27